Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1994-06-15
1995-10-03
Krass, Frederick
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424482, 427 214, 523105, 106270, 10628723, A61K 932, A61K 942
Patent
active
054550475
ABSTRACT:
A directly compressed cholestyramine tablet with a solvent-free coating is disclosed. The inner core of the tablet is made up of cholestyramine agglomerates consisting of numerous small, irregularly-shaped, jagged-edged fragments having relatively few smooth or flat surfaces with a moisture content ranging from about 8 to 14 percent by weight. A process is also disclosed for preparing cholestyramine agglomerates of the invention. The solvent-free coating comprises from about 60 percent to about 95 percent by weight of stearic acid and from about 5 percent to about 40 percent of polyethylene glycol.
REFERENCES:
patent: 3383237 (1968-05-01), Tuerck
patent: 4797288 (1989-01-01), Sharma et al.
patent: 4895723 (1990-01-01), Amer et al.
patent: 4948622 (1990-08-01), Kokubo et al.
patent: 4956182 (1990-09-01), Bequette et al.
patent: 5310558 (1994-05-01), Pozzi et al.
P. A. Tuerck, et al., J. Pharm. Sci., vol. 62, 153437 (1973).
Bequette Robert J.
Bonenberger Bruce A.
Gallian Claude E.
Reckelhoff John R.
Bristol--Myers Squibb Company
Hulina Amy
Krass Frederick
Savitsky Thomas R.
LandOfFree
Direct compression cholestyramine tablet and solvent-free coatin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Direct compression cholestyramine tablet and solvent-free coatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct compression cholestyramine tablet and solvent-free coatin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1076145